English   español  

Browsing by Author Moreau, Philippe

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2017A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myelomaLaubach, Jacob P.; Moslehi, Javid J.; Francis, Sanjeev A.; San Miguel, Jesús F. CSIC ORCID; Sonneveld, Pieter; Orlowski, R. Z.; Moreau, Philippe; Rosiñol, Laura; Faber Jr., Edward A.; Voorhees, Peter; Mateos, Maria Victoria; Marquez, Loreta; Feng, Huaibao; Desai, Avinash; Velde, Helgi van de; Elliott, Jennifer; Shi, Hongliang; Dow, Edward; Jobanputra, Nishith; Esseltine, Dixie-Lee; Niculescu, Liviu; Anderson, Kenneth; Lonial, Sagar; Richardson, Paul G.artículo
openAccessAssociation_Garderet_PV_Art2018.pdf.jpg2018Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1Garderet, Laurent; Laubach, Jacob P.; Stoppa, Anne-Marie; Hari, Parameswaran; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; Luptakova, Katarina; Lin, Jianchang; Yung, Godwin; Velde, Helgi van de; Berg, Deborah; Moreau, Philippe; Richardson, Paul G.artículo
closedAccessaccesoRestringido.pdf.jpg2018Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUSQian, Xiaozhong; Dimopoulos, Meletios A.; Amateangelo, Michael; Bjorklund, Chad; Towfic, Fadi; Flynt, Erin; Weisel, Katja C.; Ocio, Enrique M. CSIC ORCID ; Peluso, Teresa; Sternas, Lars; Zaki, Mohamed H.; Moreau, Philippe; Thakurta, Anjanartículo
closedAccessaccesoRestringido.pdf.jpg2016Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myelomaDonk, Niels W. C. J. van de; Moreau, Philippe; Plesner, Torben; Palumbo, Antonio; Gay, Francesca; Laubach, Jacob P.; Malavasi, Fabio; Avet-Loiseau, Hervé; Mateos, Maria Victoria; Sonneveld, Pieter; Lokhorst, Henk M.; Richardson, Paul G.artículo
openAccessdeepemyelo.pdf.jpg2020Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaGoldschmidt, Hartmut; Dimopoulos, Meletios A.; Rajkumar, S. Vincent; Weisel, Katja C.; Moreau, Philippe; Chng, Wee-Joo; Mikala, Gábor; Cavo, Michele; Ramasamy, Karthik; Suryanarayan, Kaveri; Teng, Zhaoyang; Labotka, Richard; Mateos, Maria Victoriaartículo
openAccesselotustud.pdf.jpg2020Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 studyDimopoulos, Meletios A.; Lonial, Sagar; White, Darrell; Moreau, Philippe; Weisel, Katja C.; San-Miguel, Jesús; Shpilberg, Ofer; Grosicki, Sebastian; Špička, Ivan; Walter-Croneck, Adam; Magen, Hila; Mateos, Maria Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Spencer, Andrew; Oakervee, Heather; Orlowski, R. Z.; Taniwaki, Masafumi; Röllig, Christoph; Einsele, Hermann; Matsumoto, Morio; Wu, Ka Lung; Anderson, Kenneth; Jou, Ying-Ming; Ganetsky, Alex; Singhal, Anil K.; Richardson, Paul G.artículo
closedAccessaccesoRestringido.pdf.jpg2012European perspective on multiple myeloma treatment strategies: Update following recent congressesLudwig, Heinz; Bladé, Joan; Cavo, Michele; Moreau, Philippe; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo
openAccessrefractorymultiplemyeloma.pdf.jpg2014Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaDimopoulos, Meletios A.; Palumbo, Antonio; Moreau, Philippe; Delforge, Michel; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2020First-in-human phase I study of ABBV-838, an antibody–drug conjugate targeting SLAMF7/CS1 in patients with relapsed and refractory multiple myelomaVij, Ravi; Nath, Rajneesh; Afar, Daniel E.H.; Mateos, Maria Victoria; Berdeja, Jesús G.; Raab, Marc S.; Guenther, Andreas; Martínez-López, Joaquín; Jakubowiak, Andrzej J.; Leleu, Xavier; Weisel, Katja C.; Wong, Shekman; Gulbranson, Scott; Sheridan, James P.; Reddy, Anita; Paiva, Bruno; Singhal, Anil K.; San Miguel, Jesús F. CSIC ORCID; Moreau, Philippeartículo
openAccessaccesoRestringido.pdf.jpg22-May-2020Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)Terpos, Evangelos; Engelhardt, Monika; Cook, Gordon; Gay, Francesca; Mateos, Maria Victoria; Ntanasis-Stathopoulos, Ioannis; Donk, Niels W. C. J. van de; Avet-Loiseau, Hervé; Hajek, Roman; Vangsted, Annette Juul; Ludwig, Heinz; Zweegman, Sonja; Moreau, Philippe; Einsele, Hermann; Boccadoro, Mario; San Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Sonneveld, Pieterartículo
closedAccessaccesoRestringido.pdf.jpg2014New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)Ocio, Enrique M. CSIC ORCID ; Richardson, Paul G.; Rajkumar, S. Vincent; Palumbo, Antonio; Mateos, Maria Victoria; Orlowski, R. Z.; Kumar, S.; Dimopoulos, Meletios A.; Merlini, Giampolo; Lahuerta, Juan José; Lonial, Sagar; Moreau, Philippe; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2019Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trialDimopoulos, Meletios A.; Gay, Francesca; Schjesvold, Fredrik; Beksac, Meral; Hajek, Roman; Weisel, Katja C.; Goldschmidt, Hartmut; Maisnar, Vladimir; Moreau, Philippe; Ki Min, Chang; Pluta, Agnieszka; Chng, Wee-Joo; Kaiser, Martin; Zweegman, Sonja; Mateos, Maria Victoria; Spencer, Andrew; Iida, Shinsuke; Morgan, Gareth J.; Suryanarayan, Kaveri; Teng, Zhaoyang; Skacel, Tomas; Palumbo, Antonio; Dash, Ajeeta B.; Gupta, Neeraj; Labotka, Richard; Rajkumar, S. Vincentartículo
closedAccessaccesoRestringido.pdf.jpg2019Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 studyMateos, Maria Victoria; Orlowski, R. Z.; Ocio, Enrique M. CSIC ORCID ; Rodríguez-Otero, Paula; Reece, Donna; Moreau, Philippe; Munshi, Nikhil; Avigan, David E.; Siegel, David S.; Ghori, Razi; Farooqui, Mohammed Z. H.; Marinello, Patricia; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessPlasma cell leukemia.pdf.jpg2013Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working GroupFernández de Larrea, Carlos; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio; Dimopoulos, Meletios A.; Chanan-Khan, Asher A.; Moreau, Philippe; Merlini, Giampolo; Lahuerta, Juan José; Bladé, Joan; Orlowski, R. Z.artículo
closedAccessaccesoRestringido.pdf.jpg2012Proteasome inhibitors in multiple myeloma: 10 years laterMoreau, Philippe; Richardson, Paul G.; Cavo, Michele; Orlowski, R. Z.; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio; Harousseau, Jean-Lucartículo
closedAccessaccesoRestringido.pdf.jpg2016Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myelomaDimopoulos, Meletios A.; Palumbo, Antonio; Corradini, Paolo; Cavo, Michele; Delforge, Michel; Di Raimondo, Francesco; Weisel, Katja C.; Oriol, Albert; Hansson, Markus; Vacca, Angelo; Blanchard, María Jesús; Goldschmidt, Hartmut; Doyen, Chantal; Kaiser, Martin; Petrini, Mario; Anttila, Pekka; Cafro, Anna Maria; Raymakers, Reinier; San Miguel, Jesús F. CSIC ORCID; Arriba, Felipe de; Knop, Stefan; Röllig, Christoph; Ocio, Enrique M. CSIC ORCID ; Morgan, Gareth J.; Miller, Neil; Simcock, Mathew; Peluso, Teresa; Herring, Jennifer; Sternas, Lars; Zaki, Mohamed H.; Moreau, Philippeartículo